Cardiac Troponin Predicts Mortality in Acute Heart Failure

Increasing s-cTnI associated with elevated in-hospital and one-year mortality risk

FRIDAY, Oct. 21 (HealthDay News) -- A sensitive cardiac troponin I (s-cTnI) assay can predict mortality risk for patients with acute heart failure, according to a study published online Oct. 11 in the Journal of Internal Medicine.

Nisha Arenja, M.D., from the University Hospital Basel in Switzerland, and colleagues investigated the prognostic and diagnostic value of a s-cTnI assay in 667 patients with acute heart failure presenting to the emergency department with acute dyspnea, who were followed for a median of 371 days. S-cTnI was stratified as being below the detection limit (<0.01 µg/L, undetectable), detectable but within the normal range (0.01 to 0.027 µg/L), and increased (≥0.028 µg/L). The final diagnosis was reviewed by two cardiologists.

The investigators found that the s-cTnI levels were significantly higher in patients with acute heart failure than in patients with acute dyspnea attributable to non-cardiac causes (median 0.02 transplant versus <0.01 µg/L). Increasing s-cTnI was associated with elevated in-hospital mortality in all three strata (2, 5, and 14 percent, respectively), and one-year mortality (21, 33, and 47 percent, respectively) for patients with acute heart failure. After adjusting for other risk factors, including B-type natriuretic peptide, s-cTnI remained an independent predictor of one-year mortality. The net reclassification and absolute integrated discrimination improvements were 68 percent and 0.18, respectively. The area under the receiver operating characteristic curve for diagnostic accuracy of s-cTnI in AHF was 0.78.

"Detectable levels of s-cTnI, even within the normal range, are independently associated with mortality," the authors write.

Full Text (subscription or payment may be required)

Physician's Briefing

Published on October 21, 2011

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ